The Role of Epithelial–Mesenchymal Transition and IGF-1R Expression in Prediction of Gefitinib Activity as the Second-Line Treatment for Advanced Nonsmall-Cell Lung Cancer

Author： Chen Bei   Xiao Feng   Li Baofeng   Xie Bo   Zhou Juan   Zheng Jihua   Zhang Weimin  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.31, Iss.7, 2013-08, pp. : 454-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

By Feliu J.   Martín G.   Castro J.   Sundlov A.   Rodriguez-Jaráiz A.   Casado E.   Lomas M.   Madroñal C.   Galán A.   Belda C.   Gonzalez-Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 527-531

Springer Publishing Company

Access to resources Recommend Favorite

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

By                          

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1430-1436

Spandidos Publications

Access to resources Recommend Favorite

Transforming growth factorβ1induced epithelial to mesenchymal transition increases mitochondrial content in the A549 nonsmall cell lung cancer cell line

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 417-421

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG0803)

By Wu Y.-L.   Zhou C.   Cheng Y.   Lu S.   Chen G.-Y.   Huang C.   Huang Y.-S.   Yan H.-H.   Ren S.   Liu Y.   Yang J.-J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 993-999

Oxford University Press

Access to resources Recommend Favorite

Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2408-2414

Spandidos Publications

Access to resources Recommend Favorite